A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure
Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are (1) to compare the effectiveness of two doses of topiramate
and (2) to assess the safety of topiramate alone in the treatment of pediatric and adult
patients with recently diagnosed epilepsy characterized by partial-onset seizures.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.